Another AI unicorn has secured 800 million in financing, with a valuation of 25 billion. Both Google and NVIDIA have invested.

According to a report by Zhidongxi on November 4th, on November 3rd, Hippocratic AI, a US-based generative AI healthcare unicorn, announced the completion of a $126 million (approximately RMB 897 million) Series C financing round. CapitalG, an independent growth fund under Alphabet, Google's parent company, participated in this investment. This round of financing has also raised the company's valuation to $3.5 billion (approximately RMB 24.924 billion), and the total financing amount has reached $404 million (approximately RMB 2.877 billion).

This also means that since the company completed its Series B financing in January this year and reached a valuation of $1.64 billion (approximately RMB 1.1678 billion), in less than a year, Hippocratic AI's valuation has more than doubled.

The latest round of financing for Hippocratic AI will be used for mergers and acquisitions, product development, and expanding international business to drive the company's expansion.

Hippocratic AI was founded in early 2023 and focuses on the AI healthcare field. It was co-founded by current CEO Munjal Shah along with multiple doctors, hospital administrators, medical professionals, and AI researchers. These medical and AI workers are from El Camino Hospital, Johns Hopkins University, Washington University in St. Louis, Stanford University, Microsoft, Google, and NVIDIA in the United States.

▲The Hippocratic AI team (Source: Social platform X)

Previously, Hippocratic AI received a $53 million (approximately RMB 377 million) Series A financing in March 2024 and a $17 million (approximately RMB 121 million) Series A extension financing in September 2024, mainly from NVIDIA's venture capital arm, NVentures. In January 2025, the company received a $141 million (approximately RMB 1.004 billion) Series B financing, with NVIDIA participating in the investment again, and the company's valuation reached $1.64 billion.

Hippocratic AI's core product is its self-developed Polaris architecture. This architecture is used to build various generative AI healthcare agents to enable real-time conversations between patients and AI and undertake non-diagnostic, patient-facing interaction tasks. In March this year, Hippocratic AI launched its latest underlying model architecture, Polaris 3.0, which includes 22 large models and 4.2 trillion parameters. It has powerful audio processing capabilities and multilingual language recognition capabilities, with an accuracy rate of up to 98.5% in health risk assessment.

▲The Polaris architecture (Source: Hippocratic AI)

Hippocratic AI claims that its products are centered around safety. The products have not only conducted 500,000 test calls with more than 7,000 licensed US clinicians but also cross-verified simulation tests with more than 115 million clinical patient records.

Currently, the company has launched more than 1,000 AI healthcare agents targeting multiple fields such as nursing, readmission prevention, and health equity, and has established partnerships with more than 50 medical institutions, including the Cleveland Clinic, Northwestern Medicine, and Ochsner Health.

▲The healthcare agents launched by Hippocratic AI (Source: Hippocratic AI)

Dimitri Zabelin, a senior AI analyst at PitchBook, a globally renowned investment tracking institution, said, "Driven by partnerships with more than 50 medical institutions, Hippocratic AI's valuation has nearly doubled in less than a year, which reflects its commercial appeal and market fit."

Oliver Rhine, the global chief strategy officer and president of Cincinnati Children's Hospital in the United States, which participated in this financing, said, "Hippocratic AI's emphasis on safety and scale aligns perfectly with Cincinnati's vision of providing high-quality pediatric care to customers. In aspects such as scheduling, chronic disease management, and daily guidance, AI assistants help Cincinnati support customers in a warmer and more precise way." Cincinnati Children's Hospital is also a long-term partner of Hippocratic AI.

Conclusion: Hippocratic AI's Valuation Doubles

Competition in the AI Healthcare Sector Intensifies

Julie Yoo, a general partner at Andreessen Horowitz (a16z), an investor, said in a statement, "The rapid development of Hippocratic AI proves that the market needs solutions to the imbalance between the supply and demand of doctors and patients."

In the third quarter of this year, the total global venture capital investment reached $97 billion, of which 46% flowed into AI companies. After the new financing, Hippocratic AI's valuation has soared. NVIDIA and Google have successively invested in the AI healthcare sector, and more and more players are entering the market. As an agent company targeting patients rather than hospitals, Hippocratic AI may face more intense market competition.

Source: Reuters

This article is from the WeChat official account "Zhidongxi" (ID: zhidxcom). The author is Wang Xinyi, and the editor is Cheng Qian. It is published by 36Kr with authorization.